Syros to Participate in Upcoming Investor Conferences
2024年5月7日 - 10:00PM
ビジネスワイヤ(英語)
Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company
committed to advancing new standards of care for the frontline
treatment of hematologic malignancies, today announced that company
management will participate in a fireside chat at two upcoming
investor conferences. Details are as follows:
JMP Securities 2024 Life Sciences Conference Date:
Tuesday, May 14 Presentation Time: 11:00 a.m. ET Location: New York
Hilton Midtown, 1335 Sixth Avenue, New York, NY
TD Cowen’s 5th Annual Oncology Innovation Summit: Insights
for ASCO & EHA Date: Wednesday, May 29 Presentation Time:
1:00 p.m. ET Location: Virtual
To access the webcasts and subsequent archived recording of each
event, please visit the Investors & Media section of the Syros
website at www.syros.com. An archived replay of each webcast will
be available for approximately 30 days following each
presentation.
About Syros Pharmaceuticals
Syros is committed to developing new standards of care for the
frontline treatment of patients with hematologic malignancies.
Driven by the motivation to help patients with blood disorders that
have largely eluded other targeted approaches, Syros is developing
tamibarotene, an oral selective RARα agonist in frontline patients
with higher-risk myelodysplastic syndrome and acute myeloid
leukemia with RARA gene overexpression. For more information, visit
www.syros.com and follow us on Twitter (@SyrosPharma) and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507063235/en/
Syros Contact Karen Hunady Director of Corporate
Communications & Investor Relations 1-857-327-7321
khunady@syros.com
Investor Contact Amanda Isacoff Stern Investor Relations,
Inc. 212-362-1200 amanda.isacoff@sternir.com
Syros Pharmaceuticals (NASDAQ:SYRS)
過去 株価チャート
から 4 2024 まで 5 2024
Syros Pharmaceuticals (NASDAQ:SYRS)
過去 株価チャート
から 5 2023 まで 5 2024